Vendor, Worcester, MA
Zata Pharmaceuticals, Inc.
UEI LM1CSJF7LLS6, CAGE 62U84
1 award and -$5,863,963 obligated between August 25, 2026 and August 25, 2026, 100% under full and open competition, against 10.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$5,863,963 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40121C00194Definitive Contract, August 25, 2026, Full and Open Competition, 10 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | No Cost Modification to Change the Period of Performance End Date to March 26, 2025.NAICS 541990, PSC AN11 | -$5,863,963 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards